Projections of non-exhaust emissions from brake wear across Japan for 2020-2050.

The concerns regarding the detrimental impacts of the increasing proportion of non-exhaust emissions are growing, even though there is a decrease in exhaust emissions from vehicles worldwide. Brake wear is a source of non-exhaust emissions. Despite the high density of traffic in Japan, the emission from brake wear has rarely been the target of studies.

Modeling the effect of improved sewage disposal rates on ecological status for aquatic organisms in Japan.

Improving sewage disposal rates is an important policy for maintaining the health of aquatic organisms in river environments. In Japan, the rate is not yet 100 %. Two measures are necessary to eliminate the discharge of untreated greywater: (1) increase the number of households connected to sewage lines in areas with sewage systems, and (2) replace single-type household onsite wastewater treatment systems (OWTSs) with combined-type systems.

Capacity assessment to secure COVID-19 waste treatment in Vietnam.

Unlabelled: The accelerated generation of COVID-19 waste under the Delta-fuelled outbreak placed a sudden burden on waste disposal in Vietnam. To secure the treatment of COVID-19 waste amid the pandemic uncertainty, treatment capacity was assessed by determining treatment occupancy rate-the ratio of estimated demand to calculated capacity-both nationally and in Ho Chi Minh City. At the general occupancy rate for COVID-19 waste treatment of 7.

Estimation of COVID-19 waste generation and composition in Vietnam for pandemic management.

Despite its initial success in COVID-19 pandemic control, Vietnam faces a growing risk of outbreaks as new infection waves driven by the highly contagious Delta variant surge in the region. In the context of preparedness through waste management, this study estimated the rate and quantity of generation and the composition of COVID-19 waste in Vietnam from the supply of resources and equipment. Over a year under COVID, 1486 t of COVID-19 waste was produced from the treatment of isolated COVID-19 patients (4.